首页> 外文期刊>Journal of Clinical Oncology >Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
【24h】

Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.

机译:影像学在早期浸润性宫颈癌的预处理评估中的作用:小组间研究的结果美国放射影像学院网络6651-妇科肿瘤组183。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To compare magnetic resonance imaging (MRI) and computed tomography (CT) with each other and to International Federation of Gynecology and Obstetrics (FIGO) clinical staging in the pretreatment evaluation of early invasive cervical cancer, using surgicopathologic findings as the reference standard. PATIENTS AND METHODS: This prospective multicenter clinical study was conducted by the American College of Radiology Imaging Network and the Gynecologic Oncology Group from March 2000 to November 2002; 25 United States health centers enrolled 208 consecutive patients with biopsy-confirmed cervical cancer of FIGO stage > or = IB who were scheduled for surgery based on clinical assessment. Patients underwent FIGO clinical staging, helical CT, and MRI. Surgicopathologic findings constituted the reference standard for statistical analysis. RESULTS: Complete data were available for 172 patients; surgicopathologic findings were consistent with FIGO stages IA to IIA in 76% and stage > or = IIB in 21%. For the detection of advanced stage (> or = IIB), sensitivity was poor for FIGO clinical staging (29%), CT (42%), and MRI (53%); specificity was 99% for FIGO clinical staging, 82% for CT, and 74% for MRI; and negative predictive value was 84% for FIGO clinical staging, 84% for CT, and 85% for MRI. MRI (area under the receiver operating characteristic curve [AUC], 0.88) was significantly better than CT (AUC, 0.73) for detecting cervical tumors (P = .014). For 85% of patients, FIGO clinical staging forms were submitted after MRI and/or CT was performed. CONCLUSION: CT and MRI performed similarly; both had lower staging accuracy than in prior single-institution studies. Accuracy of FIGO clinical staging was higher than previously reported. The temporal data suggest that FIGO clinical staging was influenced by CT and MRI findings.
机译:目的:比较磁共振成像(MRI)和计算机断层扫描(CT),并与国际妇产科联合会(FIGO)在早期浸润性宫颈癌的预处理评估中的临床分期进行比较,以外科病理学结果作为参考标准。病人与方法:这项前瞻性多中心临床研究是由美国放射影像学院和妇科肿瘤学小组于2000年3月至2002年11月进行的。美国25个健康中心招募了208例经活检证实为FIGO≥IB期宫颈癌的患者,这些患者已根据临床评估计划进行手术。患者接受了FIGO的临床分期,螺旋CT和MRI检查。手术病理结果构成了统计分析的参考标准。结果:有172例患者的完整数据。外科病理学发现与FIGO IA至IIA阶段(占76%)和≥IIB阶段(占21%)一致。对于晚期(>或= IIB)的检测,FIGO临床分期(29%),CT(42%)和MRI(53%)的敏感性差。 FIGO临床分期的特异性为99%,CT为82%,MRI为74%。 FIGO临床分期的阴性预测值为84%,CT为84%,MRI为85%。 MRI(接受者工作特征曲线下的面积[AUC]为0.88)在检测子宫颈肿瘤方面明显优于CT(AUC为0.73)(P = .014)。对于85%的患者,在进行MRI和/或CT后提交FIGO临床分期表。结论:CT和MRI表现相似。两者的分期准确性均低于先前的单机构研究。 FIGO临床分期的准确性高于先前报道的水平。时间数据表明,FIGO的临床分期受CT和MRI结果的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号